A. Thomas McCourt's most recent trade in Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 103,526 Class A Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.66 per share. | 23 Feb 2026 | 103,526 | 1,489,002 (0%) | 0% | 3.7 | 378,905 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 23 Feb 2026 | 94,757 | 1,592,528 (1%) | 0% | 3.8 | 361,024 | Class A Common Stock |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 540,000 | 1,687,281 (1%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 16 May 2025 | 13,353 | 1,147,281 (0%) | 0% | 0.6 | 7,745 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 139,064 | 1,160,634 (0%) | 0% | 1.8 | 244,753 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 147,354 | 1,299,698 (0%) | 0% | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 20 May 2024 | 67,618 | 1,150,330 (0%) | 0% | 6.4 | 436,136 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 120,298 | 0 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 120,298 | 1,217,948 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 264,876 | 1,097,650 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 132,438 | 132,438 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | A. Thomas McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 12 Feb 2024 | 177,164 | 832,774 (0%) | 0% | 15.2 | 2,699,979 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | A. Thomas McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 249,617 | 1,009,938 (0%) | 0% | 0 | Class A Common Stock | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.70 per share. | 30 May 2023 | 26,632 | 758,284 (0%) | 0% | 10.7 | 284,962 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 22 May 2023 | 36,000 | 784,916 (0%) | 0% | 10.1 | 364,320 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.62 per share. | 08 May 2023 | 21,148 | 820,916 (0%) | 0% | 10.6 | 224,592 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.67 per share. | 27 Mar 2023 | 46,129 | 842,064 (0%) | 0% | 10.7 | 492,196 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 240,595 | 888,193 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 120,297 | 120,297 | - | - | Performance-based Restricted Stock Units | |
| Pliant Therapeutics Inc | Thomas A. McCourt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.22 per share. | 03 Mar 2023 | 33,756 | 647,598 (0%) | 0% | 11.2 | 378,742 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 26,639 | 685,942 (0%) | 0% | 11.3 | 301,287 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 25,595 | 716,990 (0%) | 0% | 11.4 | 292,039 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 4,588 | 681,354 (0%) | 0% | 11.3 | 51,890 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 4,409 | 712,581 (0%) | 0% | 11.4 | 50,307 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 30,145 | 742,585 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 05 Jan 2023 | 110,962 | 712,440 (0%) | 0% | 12.1 | 1,339,311 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 110,962 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.65 per share. | 05 Jan 2023 | 110,962 | 823,402 (0%) | 0% | 11.6 | 1,292,707 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 03 Oct 2022 | 18,899 | 712,440 (0%) | 0% | 10.4 | 196,739 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.65 per share. | 01 Sep 2022 | 26,446 | 731,339 (0%) | 0% | 10.7 | 281,650 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.35 per share. | 01 Aug 2022 | 23,229 | 757,785 (0%) | 0% | 11.3 | 263,649 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 30 Jun 2022 | 19,959 | 778,922 (0%) | 0% | 11.6 | 231,125 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 21,873 | 810,729 (0%) | 0% | 11.5 | 251,540 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 11,848 | 798,881 (0%) | 0% | 11.5 | 136,252 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 23 May 2022 | 2,587 | 832,602 (0%) | 0% | 11.5 | 29,751 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 248,869 | 835,189 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 19,970 | 602,806 (0%) | 0% | 10.8 | 215,077 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 16,486 | 586,320 (0%) | 0% | 10.8 | 177,554 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 10,026 | 622,776 (0%) | 0% | 10.8 | 107,980 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 28 Feb 2022 | 1,942 | 632,802 (0%) | 0% | 10.8 | 20,915 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 60,290 | 634,744 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 22 Dec 2021 | 46,327 | 574,454 (0%) | 0% | 11.4 | 528,591 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 23 Nov 2021 | 52,644 | 618,545 (0%) | 0% | 11.6 | 609,618 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 104,690 | 671,189 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | President and Interim CEO | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 24 May 2021 | 1,716 | 566,499 (0%) | 0% | 12.3 | 21,021 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | President and Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 96,638 | 568,215 (0%) | 0% | 0 | Class A Common Stock |